COMMUNIQUÉS West-GlobeNewswire

THC Therapeutics, Inc. Announces Filing of 10-K and Provides Corporate Update
03/03/2026
JACKSBORO, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (OTC: THCT), a dynamic and growing cannabis company, issued a shareholder update today. To our valued friends and shareholders, We hope that [...]
Vericel to Present at Multiple Upcoming Investor Conferences
03/03/2026
CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present [...]
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
03/03/2026
CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
rYojbaba Announces $3.2 Million Comprehensive Global Labor Support and Union Infrastructure Development Agreement with International Labor Union
03/03/2026
FUKUOKA, Japan, March 03, 2026 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”) , a Japanese consulting and health services company, announced a Comprehensive Agreement on [...]
Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call
03/03/2026
MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic [...]
Propanc Biopharma’s Lead Asset PRP Shows >85% Tumor Growth Inhibition in Preclinical Pancreatic Models
03/03/2026
PRP May Outshine Traditional Therapies in a Booming $4.4 Billion Market MELBOURNE, Australia, March 03, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical [...]
INVO Fertility’s Wisconsin Clinic Joins Progyny Network
03/03/2026
INVO’s Wisconsin Clinic is now in-network for Progyny members, expanding the clinic’s market reach MIDDLETON, Wis. and SARASOTA, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO [...]
Immix Biopharma to Participate in Upcoming Investor Conferences
03/03/2026
LOS ANGELES, CA, March 03, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present [...]
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
03/03/2026
Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains 53% of people surveyed rank sleep as the most important behavior for a long, healthy life, ahead [...]
SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments
03/03/2026
March 3, 2026 With a total budget of EUR 21.5 million, the four-year SHERPA research project is coordinated by Philips and co-funded by the EU Innovative Health Initiative (IHI) and industry partners The project focuses [...]
Quell Therapeutics Initiates CHILL Phase 1/2 Trial of Novel QEL-005 CAR-Treg Therapy in Refractory Rheumatoid Arthritis and Systemic Sclerosis Following UK CTA Approval
03/03/2026
London, UK – 3 March, 2026 – Quell Therapeutics Ltd (“Quell”), today announced that it has initiated a Phase 1/2 basket clinical study evaluating its autologous CAR-Treg therapy, QEL-005, in patients with Rheumatoid [...]
Quell Therapeutics Demonstrates Safety, Phenotypic Stability, Durability and Early Efficacy with Phenotype‑Locked™ CAR‑Tregs in LIBERATE Phase 1/2 Liver Transplant Study
03/03/2026
London, UK – 3 March, 2026 – Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, today shared interim top- [...]
SNIPR announces Publication of Final Positive Phase 1 Results for SNIPR001 in The Lancet Microbe
03/03/2026
First-ever randomized, placebo-controlled Phase 1 trial - published in The Lancet Microbe - supports SNIPR001’s safety, tolerability, and restriction to the gastrointestinal tract in healthy participants Oral SNIPR001 [...]
Montis Biosciences Advances First-in-Class Dual-Action C1q Antibody with Strong Preclinical Proof-of-Concept in Neuroinflammatory Diseases
03/03/2026
Lead antibody MB0109 targets C1q and uniquely inhibits both classical complement cascade and C1q-mediated macrophage/microglial activation — two key drivers of neuroinflammation MB0109 demonstrated statistically [...]
AEON Clinic Introduces Exomind to Treat OCD ADHD PTSD And Other Complex Mental Health Conditions
03/03/2026
The Future of Mental Sovereignty: AEON Clinic Launch EXOMIND™ at Atlantis The Royal DUBAI, United Arab Emirates, March 03, 2026 (GLOBE NEWSWIRE) -- AEON Clinic, a top pioneer in regenerative medicine and opulent [...]
Fagron completes acquisition of Vepakum
03/03/2026
Regulated information – inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 3 March 2026 – 7:00AM Fagron completes acquisition of Vepakum Fagron, the leading global player in pharmaceutical compounding, [...]
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
03/03/2026
LOUISVILLE, Ky., March 02, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex [...]
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
03/03/2026
Financing included participation by healthcare-dedicated investors alongside existing shareholders CHICAGO, IL, March 02, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company [...]
Care@Home 4 Life Announces the Appointment of Industry Veteran Daniel Peters as Regional Sales Director
03/03/2026
Peters brings over 15 years of senior care and financial expertise to advance Care@Home 4 Life's mission of keeping seniors safely in the homes they love. Miami, FL, March 02, 2026 (GLOBE NEWSWIRE) -- Care@Home 4 Life [...]

Pages